High mutations in fatty acid metabolism contribute to a better prognosis of small‐cell lung cancer patients treated with chemotherapy

BACKGROUND: The majority of patients with small‐cell lung cancer (SCLC) show a good response in the early stages of treatment, but more than 90% of patients will develop drug resistance. Therefore, biomarkers are urgently needed to identify patients who can benefit from systemic treatment. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Lyu, Qiong, Zhu, Weiliang, Wei, Ting, Ding, Weimin, Cao, Manming, Wang, Qiongyao, Guo, Linlang, Luo, Peng, Zhang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Bioinformatics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559513/
https://www.ncbi.nlm.nih.gov/pubmed/34564955
http://dx.doi.org/10.1002/cam4.4290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559513/
https://www.ncbi.nlm.nih.gov/pubmed/34564955
http://dx.doi.org/10.1002/cam4.4290

Ejemplares similares